215 filings
PRE 14A
EYEN
Eyenovia Inc
Preliminary proxy
23 Apr 24
5:12pm
8-K
EYEN
Eyenovia Inc
10 Apr 24
Other Events
8:00am
424B5
EYEN
Eyenovia Inc
9 Apr 24
Prospectus supplement for primary offering
7:11pm
8-K
EYEN
Eyenovia Inc
9 Apr 24
Entry into a Material Definitive Agreement
8:45am
8-K
EYEN
Eyenovia Inc
8 Apr 24
Other Events
5:23pm
8-K
31dhnkyo3ujobgo
19 Mar 24
Regulation FD Disclosure
8:39am
8-K/A
5w12qdnfd
31 Jan 24
Regulation FD Disclosure
8:13am
8-K
kfb lg0y5ohdh
25 Jan 24
Regulation FD Disclosure
7:59am
8-K
fp5nlzt
16 Jan 24
Eyenovia Re-Acquires Development and Commercialization Rights to MicroPine
8:24am
8-K
oxmol3z1nua s9
13 Nov 23
Eyenovia Reports Third Quarter 2023 Financial Results and Provides Business Update
4:15pm
8-K
4ojb8ty l34g2w67ou
20 Sep 23
Regulation FD Disclosure
8:23am
424B3
12smvm7b
29 Aug 23
Prospectus supplement
6:27pm
8-K
lebaf
29 Aug 23
Eyenovia Announces $12 Million Registered Direct Offering
8:19am
424B5
ytbz85
25 Aug 23
Prospectus supplement for primary offering
12:07pm
8-K
pr6yx6 ai
16 Aug 23
Eyenovia Acquires U.S. Commercial Rights to APP13007 (Clobetasol Propionate Ophthalmic Nanosuspension, 0.05%) from Formosa Pharmaceuticals
7:31am
8-K
gjh3wljc1b9 gho0669
10 Aug 23
Eyenovia Reports Second Quarter 2023 Financial Results and Provides Business Update
4:18pm
S-8
gxam39alkvvw
27 Jun 23
Registration of securities for employees
5:21pm